Global Nystatin and Triamcinolone Acetonide Market Size, Share and Trends Analysis Report, By Type (Cream and Ointment) and By Application (Hospitals, Drug Stores, and Others) Forecast 2022-2028

The global nystatin and triamcinolone acetonide market is anticipated to grow at a significant CAGR of 4.5% during the forecast period 2022-2028. The growth of the market is attributed to the rising cases of eczema, psoriasis, and dermatitis globally. According to National Eczema Association (NEA), 31.6 million 10.1% of people in the US have some form of eczema. Approximately 9.6 million US children under the age of 18 have atopic dermatitis. An estimated 16.5 million US adults have an AD that initially began at 2 years of age, with nearly 40% affected by moderate or severe disease. According to the American Academy of Dermatology (AAD), approximately 7.5 million people in the US have psoriasis. It occurs in all age groups but is primarily seen in adults, with the highest proportion between ages 45 and 64.6. Approximately 25-30% of people with psoriasis experience joint inflammation that produces symptoms of arthritis. The growing demand for the treatment of these infectious diseases is propelling the growth of the market. There is a surge in demand for topical corticosteroids and antifungal drugs.

The market is segmented based on type and application. Based on the type, the market is sub-segmented into cream and ointment. Based on application, the market is sub-segmented into hospitals, drug stores, and others. Among these segments, the hospital segment is anticipated to hold a prominent share in the market due to the increasing cases of infectious skin diseases such as eczema, dermatitis, psoriasis and many more. Triamcinolone with Nystatin Acetonide is an antifungal drug that is used to treat yeast infections on the skin. It works by eradicating the infection-causing yeast. The treatment of such infectious diseases is done in hospitals and therefore, the segment is propelling the growth of the market.

Some major players in the market include Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc. and Teva Pharmaceutical Industries Ltd. among others. The market players are helping significantly in the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay in the competition of the market. For instance, in March 2022, Alembic Pharmaceuticals announced that its joint venture Aleor Dermaceuticals had received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application for nystatin and triamcinolone acetonide cream USP, 100,000 units/gram and 1 mg/gram

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Perrigo Co. PLC, Taro Pharmaceutical Industries Ltd., Mylan NV, Lupin Inc. and Teva Pharmaceutical Industries Ltd. among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Nystatin and Triamcinolone Acetonide Nasal Market Report by Segment

By Type

• Cream
• Ointment

By Application

• Hospital
• Drug Stores
• Others

Global Nystatin and Triamcinolone Acetonide Nasal Market Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa